Detalhe da pesquisa
1.
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.
Lancet Oncol
; 25(1): 117-125, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092009
2.
Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.
J Transl Med
; 14: 259, 2016 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27599546
3.
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.
PLoS Pathog
; 10(10): e1004473, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25393648
4.
Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay.
Br J Haematol
; 183(1): 146-149, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28880377
5.
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma.
Transplant Cell Ther
; 28(6): 284-293, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35306217
6.
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
Eur J Haematol
; 82(6): 426-32, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19302559
7.
The use of experimental murine models to assess novel agents of hematopoietic stem and progenitor cell mobilization.
Biol Blood Marrow Transplant
; 14(6): 603-21, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18489986
8.
Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma.
Oncotarget
; 9(90): 36126-36136, 2018 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30546832
9.
Understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sézary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data.
Eur J Cancer
; 156 Suppl 1: S18, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649645
10.
A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer.
Oncotarget
; 7(23): 34582-98, 2016 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27153556
11.
Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma.
Blood Cancer J
; 11(10): 169, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671024
12.
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
Am J Med
; 112(4): 262-8, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11893364
13.
A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapy.
Haematologica
; 93(5): 789-90, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18450737